Evidence map›Paper›PMID 31203527›Full record

GuidelineInternational journal of clinical oncology2020

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.

Yojiro Hashiguchi, Kei Muro, Yutaka Saito, Yoshinori Ito, Yoichi Ajioka, Tetsuya Hamaguchi, Kiyoshi Hasegawa, Kinichi Hotta, Hideyuki Ishida, Megumi Ishiguro and 28 more

4 registry-linked trialsAbstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in International journal of clinical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 1,161 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,161citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04150081 unknown statusnot on this map

Endoscopic Versus Surgical Treatment for T1 Colorectal Cancer: a Population-based Cohort Study

TypeobservationalSponsorHospital Clinic of BarcelonaRan2019 to 2022Enrolled1,400ConditionsColorectal CancerArmsSurgery or Endoscopic treatment
NCT06043999 narecruitingnot on this mapstarted 2023, after this paper: background citation

A Prospective, Multicenter, Randomized, Open, Parallel Controlled, Non-inferiority Clinical Trial of Salvage Chemoradiotherapy Versus Radical Total Mesorectal Excision in the Treatment of Intermediate-risk Early Middle-low Rectal Cancer After Local Resection

TypeinterventionalSponsorSun Yat-sen UniversityRan2023 to 2028Enrolled392ConditionsChemotherapy Effect, Rectal CancerArmsRadical total mesorectal excision, Salavge Adjuvant Chemoradiotherapy
NCT06096493 unknown statusnot on this mapstarted 2023, after this paper: background citation

Predictors of Disease Free Survival After Curative Cancer Rectum Surgery

TypeobservationalSponsorSouth Valley UniversityRan2023 to 2023Enrolled200ConditionsRectal CancerArmscurative surgery for cancer rectum
NCT06314971 completednot on this mapstarted 2023, after this paper: background citation

Predicting Recurrence After Curative-Intent Resection of T1 Colorectal Cancer With Transcriptomics

TypeobservationalSponsorCity of Hope Medical CenterRan2023 to 2025Enrolled138ConditionsColorectal Cancer, Colorectal Neoplasms, Colorectal Adenocarcinoma, Colorectal Cancer Stage IArmsTw1CE
3 · Its place in the literature

Who cites it

1,161 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Guideline
  7. Pooled it
  8. Pooled it
  9. Guideline
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. Article

1,101 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Yojiro HashiguchiDepartment of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan. yhashi@med.teikyo-u.ac.jp.ORCID http://orcid.org/0000-0002-6178-2574
Kei MuroDepartment of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Yutaka SaitoEndoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Yoshinori ItoDepartment of Radiation Oncology, Showa University School of Medicine, Tokyo, Japan.
Yoichi AjiokaDivision of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
Tetsuya HamaguchiDepartment of Gastroenterological Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
Kiyoshi HasegawaHepato-Biliary-Pancreatic Surgery Division, Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kinichi HottaDivision of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
Hideyuki IshidaDepartment of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Megumi IshiguroDepartment of Chemotherapy and Oncosurgery, Tokyo Medical and Dental University Medical Hospital, Tokyo, Japan.
Soichiro IshiharaDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yukihide KanemitsuDepartment of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan.
Yusuke KinugasaDepartment of Gastrointestinal Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Keiko MurofushiDepartment of Radiation Oncology, faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Takako Eguchi NakajimaDepartment of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan.
Shiro OkaDepartment of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.
Toshiaki TanakaDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hiroya TaniguchiDepartment of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
Akihito TsujiDepartment of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Keisuke UeharaDivision of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Aichi, Japan.
Hideki UenoDepartment of Surgery, National Defense Medical College, Saitama, Japan.
Takeharu YamanakaDepartment of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan.
Kentaro YamazakiDivision of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Masahiro YoshidaDepartment of Hepato-Biliary-Pancreatic and Gastrointestinal Surgery, School of Medicine, International University of Health and Welfare, Narita, Japan.
Takayuki YoshinoDepartment of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
Michio ItabashiDepartment of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
Kentaro SakamakiCenter for Data Science, Yokohama City University, Yokohama, Japan.
Keiji SanoDepartment of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan.
Yasuhiro ShimadaDivision of Clinical Oncology, Kochi Health Sciences Center, Kochi, Japan.
Shinji TanakaDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Hiroyuki UetakeDepartment of Specialized Surgeries, Tokyo Medical and Dental University, Tokyo, Japan.
Shigeki YamaguchiDepartment of Gastroenterological Surgery, Saitama Medical University International Medical Center, Hidaka, Japan.
Naohiko YamaguchiLibrary of SEIREI, SAKURA Citizen Hospital, Sakura, Japan.
Hirotoshi KobayashiDepartment of Surgery, Mizonokuchi Hospital, Teikyo University School of Medicine, Kanagawa, Japan.
Keiji MatsudaDepartment of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan.
Kenjiro KotakeDepartment of Surgery, Sano City Hospital, Tochigi, Japan.
Kenichi SugiharaTokyo Medical and Dental University, Tokyo, Japan.
Japanese Society for Cancer of the Colon and Rectum

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of deaths from colorectal cancer in Japan continues to increase. Colorectal cancer deaths exceeded 50,000 in 2016. In the 2019 edition, revision of all aspects of treatments was performed, with corrections and additions made based on knowledge acquired since the 2016 version (drug therapy) and the 2014 version (other treatments). The Japanese Society for Cancer of the Colon and Rectum guidelines 2019 for the treatment of colorectal cancer (JSCCR guidelines 2019) have been prepared to show standard treatment strategies for colorectal cancer, to eliminate disparities among institutions in terms of treatment, to eliminate unnecessary treatment and insufficient treatment and to deepen mutual understanding between healthcare professionals and patients by making these guidelines available to the general public. These guidelines have been prepared by consensuses reached by the JSCCR Guideline Committee, based on a careful review of the evidence retrieved by literature searches and in view of the medical health insurance system and actual clinical practice settings in Japan. Therefore, these guidelines can be used as a tool for treating colorectal cancer in actual clinical practice settings. More specifically, they can be used as a guide to obtaining informed consent from patients and choosing the method of treatment for each patient. Controversial issues were selected as clinical questions, and recommendations were made. Each recommendation is accompanied by a classification of the evidence and a classification of recommendation categories based on the consensus reached by the Guideline Committee members. Here, we present the English version of the JSCCR guidelines 2019.

Indexed as

Colorectal NeoplasmsConsensusEvidence-Based MedicineHumansJapanMedical OncologyChemotherapyColorectal cancerEndoscopyGuidelineRadiotherapySurgery

Identifiers

PMID31203527
PMCPMC6946738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.